Results 91 to 100 of about 4,707 (174)

ePosters Virtual

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Tenecteplase Treatment and Thrombus Characteristics Associated with Early Reperfusion: An EXTEND-IA TNK Trials Analysis

, 2023
Background: Intracranial occlusion site, contrast permeability, and clot burden are thrombus characteristics that influence alteplase-associated reperfusion.
F Alemseged (13359393), H Rice (13339959), L Churilov (5578286), P Guha (16680852), G Sharma (13359459), Hamed Asadi (13059153), M Brooks (9863258), V Yogendrakumar (13359381), D Leggett (13359411), GA Donnan (7735055), H Brown (9887666), H Zhao (7714700), B Yan (13315452), SM Davis (7918565), R Dowling (12024), PJ Mitchell (8847788), F Miteff (13339929), K Redmond (13359408), S Bush (13359390), F Ng (13290303), V Thijs (9905232), TY Wu (14472327), MW Parsons (7735073), TJ Kleinig (14632247), T Wijeratne (7723529), HM Dewey (14448186), R Scroop (13339944), L De Villiers (13359402), PM Desmond (10456412), C Levi (7755545), T Ang (13339941), N Yassi (13318206), J Beharry (16680855), BCV Campbell (8847776)   +33 more
core  

Thrombolysis for acute ischaemic stroke with tenecteplase in a developing country: challenges and experience from a prospective observational study

Egyptian Journal of Neurosurgery
Context This study will emphasise the importance of Tenecteplase being ideally suited as a first-choice drug for thrombolysis in AIS in developing countries, considering the numerous challenges which are faced in these parts of the world.
Neeraj Basantani, Vijay Kumar Gupta, Sanjay Kumar, Amit Narang   +3 more
doaj   +1 more source

Comparison of pharmacokinetic properties of alteplase and tenecteplase. The future of thrombolysis in acute ischemic stroke

Introduction: The drug most frequently used for thrombolysis in cases of acute ischemic stroke (AIS) is alteplase. However, there is moderate-to-high-quality evidence that tenecteplase has similar or higher efficacy and safety.
Gentile C., Valente M., Merlino G., Lorenzut S., Gigli G. L., Tereshko Y., Mare A., Marinig R., Janes F.   +8 more
core   +1 more source

Occlusion site and outcomes in intra-arterial tenecteplase after successful endovascular therapy: a secondary analysis of the ANGEL-TNK trial. [PDF]

J Neurointerv Surg
Li S, Tong X, Zhang H, Luo G, Song L, Sun D, Chen W, Yao X, Zhou Q, Zhang X, Xu Y, Nguyen TN, Miao Z, Huo X.   +13 more
europepmc   +1 more source

Early Reperfusion in Basilar Artery Occlusion Stroke Managed With Tenecteplase Versus Alteplase Before Endovascular Treatment. [PDF]

Stroke Vasc Interv Neurol
Wolman DN, Karamchandani RR, Darko K, Bielinski TM, Goyal N, Rhoten JB, Jayaraman MV, Sidebottom CT, Gross BA, Al-Bayati AR, Doheim MF, Tobin MK, Chinthala A, Gajjar A, Mascitelli J, Webb MR, Burkhardt JK, Scott KW, Srinivasan V, Tonetti D, Koneru M, Altschul DJ, Vaishnav D, Multani S, Theofanis T, Ares WJ, Sone JY, Zand R, Bahrami S, Li J, Defilipp G, Strong D, Torabi R, Moldovan K, Schirmer CM, Nogueira RG, Bohnstedt BN, Paul AR, Hendrix P.   +38 more
europepmc   +1 more source

Tenecteplase versus alteplase before thrombectomy for ischemic stroke

Background: Intravenous infusion of alteplase is used for thrombolysis before endovascular thrombectomy for ischemic stroke. Tenecteplase, which is more fibrin-specific and has longer activity than alteplase, is given as a bolus and may increase the ...
M. Brooks (2926488), P. J. Mitchell (12783818), T. Ang (21326969), Mark Parsons (21141701), T. J. Kleinig (21326975), S. J. Bush (21326981), R. Scroop (21326954), Christopher Levi (21132938), L. Churilov (6530540), V. Thijs (17194843), R. J. Dowling (21326978), H. Asadi (21326957), H. M. Dewey (18838075), D. G. Shah (21326963), T. J. Wijeratne (21326966), Ferdinand Miteff (21132695), T. Y. Wu (21326960), B. Yan (6511301), M. Simpson (7622078), B. C. V. Campbell (21326951), N. Yassi (21326972)   +20 more
core  

Tenecteplase in acute ischemic stroke: an updated meta-analysis. [PDF]

Front Neurol
Almohammed H, Morad AS, Bin Saddiq BW, Almuhaysin FI, Al Zoabi BMK, Aldawsari WA, Khan TN, Thalib HI, Alabdi Z.   +8 more
europepmc   +1 more source

A Bayesian conditional probability simulation framework for pre-hospital stroke transport decisions in the tenecteplase era: decision boundaries, global sensitivity, and stochastic dominance. [PDF]

Front Neurol
Çalışır T.
europepmc   +1 more source

Fulminant Amyloid-β-Related Angiitis after Tenecteplase: A Biopsy-Confirmed Cause of Post-Thrombolysis Neurologic Deterioration. [PDF]

Neurohospitalist
Schweitzer C, Durai K, Kadakia S, Zeigler G, Pham K.   +4 more
europepmc   +1 more source